Granulocyte macrophage colony stimulating factor market is anticipated to grow at a significant CAGR during the forecast period. Granulocyte macrophage colony-stimulating factor, also called as CSF2 (colony stimulating factor 2), is a monomeric glycoprotein released by usual killer cells, T cells, mast cells, macrophages, fibroblasts, and endothelial cells that acts as a cytokine. The COVID-19 pandemic has significantly affected the global granulocyte macrophage colony stimulating factor market. Since this factor is a myelopoietic development factor and pro-inflammatory cytokine, it plays a key role in the treatment of immunological disease, lung inflammation, and alveolar macrophage homeostasis. Further, the inhibition as well as administration of granulocyte macrophage colony stimulating factor, both are now being medically tested in COVID-19 clinical trials.
Other major factors attributable to the market growth includes the increasing prevalence of fungal infections, the rising prevalence of cancer, and the growing cases of failed skin grafting. Apart from COVID-19, the growing cancer cases substantially impact the market growth. North America region is likely to witness a significant growth in the market owing to the rising prevalence of cancer. This influences the market growth in the North American region. On the other side, the exorbitantly high cost of chemotherapy treatments, and side effects associated with the drug may restrain the growth of the global granulocyte macrophage colony stimulating factor market.
To Request a Sample of our Report on Granulocyte Macrophage Colony Stimulating Factor Market: https://www.omrglobal.com/request-sample/granulocyte-macrophage-colony-stimulating-factor-market
Market Coverage
- The market number available for – 2021-2029
- Base year- 2021
- Forecast period- 2023-2029
Segment Covered-
- By Route of Administration
- By Application
- By End-User
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Amgen Inc., Merck KGaA, and Sanofi S.A., among others.
Granulocyte Macrophage Colony Stimulating Factor Market Report by Segment
By Route of Administration
- Subcutaneous Bolus
- Intravenous Infusion
By Application
- Fungal Infections
- Skin Graft
- Cut-Burn Wounds
- Acute Myelogenous Leukemia
- Others
By End-User
- Hospitals and Clinics
- Surgical Centers
- Diagnostic Centers
- Research Centers
- Others
A full Report of Granulocyte Macrophage Colony Stimulating Factor Market is Available @ https://www.omrglobal.com/industry-reports/granulocyte-macrophage-colony-stimulating-factor-market
Granulocyte Macrophage Colony Stimulating Factor Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
